Archives

by in
Entry Author Date Location
MD Anderson Expands “Moon Shots” Immunotherapy Partnership to J&J 01/21/14 Texas
East Coast Biotech Roundup: Gerngross, Akili, Intercept, & More 01/10/14 Boston
Akili, Pfizer, and the Rise of Videogame Brain Therapies 01/09/14 Boston
Tillman Gerngross, the Scientist Turned Scientific Businessman 01/09/14 Boston
Flexion Files for IPO, Seeks $86M to Develop Osteoarthritis Drugs 01/08/14 Boston
Houston’s MD Anderson Partners With Pfizer on Cancer Immunotherapies 01/08/14 Texas
Stem Cells, Inc. Expanding Trial in Age-Related Eye Affliction 12/18/13 San Francisco
What Was Hyped, and What Fell Out of Favor, This Year in Biotech 12/16/13 National
Sam Sia’s NY Biotech Incubator Already Bustling With 16 Startups 12/13/13 New York
12 Things the Pharma Industry Can Do to Rebuild Real Public Trust 12/09/13 National
NYCEDC Amassing $100M Biotech Fund; Boehringer Jumps Into Kendall Square 12/04/13 New York
Visterra Adds $8M, Ex-Amag Execs, To Begin Clinical Push for Flu Antibody 12/02/13 Boston
Gates Foundation Health Chief on Coaxing Pharma to Do Good 11/25/13 National
Zalicus Awaits Day of Reckoning, Braces For Key Pain Drug Results 11/11/13 Boston
MVCA Celebrates Year’s Top Deals, Names New Board Chair 11/08/13 Detroit
Alzheon Emerges From Stealth, Hunts for Alzheimer’s Castoffs 10/23/13 Boston
Regeneron, Sanofi Pass First Key Test With Cholesterol-Lowering Drug 10/16/13 New York
San Diego Life Sciences Roundup: Fate, Ligand, BioNano, and More 10/04/13 San Diego
Sutro Aims to Deliver Anti-Tumor “Warheads” More Precisely 10/01/13 San Francisco
Langer’s Bind Therapeutics Prices IPO at $15 Per Share 09/20/13 Boston
Tom Maniatis’ Dream of a NY Genome Center Becomes a Big Apple Reality 09/19/13 New York
Disappointments, New Prospects for Rigel Pharmaceuticals 09/10/13 San Francisco
East Coast Life Sciences Roundup: Aileron, Enzymatics, Acton, & More 09/06/13 Boston
Syndax Pockets $26.6M For Final Stage Push With Cancer Drug 08/27/13 Boston
Buoyed by Partnerships, Bind Therapeutics Floats $80.5M IPO Plan 08/12/13 Boston
Atlas Startup, Rodin, Hopes to Rewire Neurons to Improve Memory 08/12/13 Boston
Six Reasons Why Giving Scientists Big Bonuses Won’t Fix Pharma R&D 08/12/13 National
Celgene Partner Acceleron Files For IPO; Plans to Raise Up to $75M 08/07/13 Boston
Ensemble Reels in Novartis to Develop Oral, Mid-Sized Inflammation Drugs 08/06/13 Boston
East Coast Biotech Roundup: Cubist, Acetylon, Foundation, & More 08/02/13 Boston
Page 2 of 18 « previous page · next page »